To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

Semaglutide (Ozempic, Wegovy) may help reduce the risk of an opioid overdose in certain people, an emulation target trial ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...

According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1, which is what ...

This partnership aligns with both companies' strategies to address the growing demand for effective diabetes treatments in ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Biocon Ltd has entered a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to market GLP-1 ...

Under the terms of this agreement, Biocon will develop and manufacture the products, and Tabuk Pharmaceuticals will hold the ...

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular ...

If you've ever wondered why losing weight seems more challenging for you than others, you're not alone. Studies show that up ...